Irem Durmaz Sahin

7PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2026
Benchmarking Ultra-Low Attachment and Photopatterned GelMA 3D Culture Platforms for Modeling Cancer Stemness in High-Grade Serous Ovarian Cancer.

|Mar 13, 2026
Biological evaluation of novel 6,9-disubstituted purine analogues in high-grade serous ovarian cancer cell lines.

Duygu Altiparmak, Deren Demirel Yavuz, Pınar Kul Karadenizli

|Oct 07, 2025
Targeting Ovarian Cancer With Pyrimidine Nucleobase and Nucleoside Analogs: Synthesis, In Vitro Cytotoxic Activity, and Molecular Docking.

Hilal Zivali, Arya Akdağ, Büşra Demirkan

|Mar 28, 2024
Exploration of novel 6,8,9-trisubstituted purine analogues: synthesis, in vitro biological evaluation, and their effect on human cancer cells.

Muhammed Fatih Polat, İrem Durmaz Şahin, Rengül Atalay

|Dec 09, 2023
Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells.

Elif Merve Aydin, İdil Su Canıtez, Eleonora Colombo

|Jan 15, 2021
Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer.

Jenny-Maria Jönsson, Maria Bååth, Ida Björnheden

Pageof 2

Frequent Collaborators

3 joint publications

Meral Tunçbilek

2 joint publications

Daniele Passarella

2 joint publications

Rengul Cetin-Atalay

1 joint publications

Altay Koyas